Dr. Joseph Horrigan


Photo by Edsel Little.

DOCTOR. Horrigan does not have autism, but he does work with children who have ASD. As a psychiatrist, he helps treatment programs to address the child’s individual needs. Horrigan’s perspective is influenced by his background in developing and testing pediatric drugs with GlaxoSmithKline.

Dr. Joseph Horrigan works at Duke University as a pediatric neuropsychiatrist. He graduated from the University of Rochester School of Medicine and Dentistry, obtaining his degree in psychiatry.

Horrigan is a man of many jobs. He has worked in many prestigious places such the University of North Carolina at Chapel Hill, where he served on the faculty and was a clinician. He had also worked at pharmaceutical company GlaxoSmithKline.

Later joining Autism Speaks, which looks to develop better medication for those with autism spectrum disorders, Horrigan helped children that have “complicated clinical challenges.” Additionally, he offers his services at a residential treatment facility without charge for low income families. Many of his patients have autism spectrum disorders.

At Autism Speaks he was the Head of Medical Research before eventually moving to work at AMO Pharma as Chief Medical Officer in the United Kingdom to help discover new treatment for rare genetic disorders.

Despite shifting jobs a couple of times, his passion for his work has never dwindled.